Unknown

Dataset Information

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.


ABSTRACT:

Background

Individual serum biomarkers are neither adequately sensitive nor specific for use in screening the general population for ovarian cancer. The purpose of this study was to develop a multiprotein classifier to detect the early stages of ovarian cancer, when it is most treatable.

Methods

The Olink Proseek Multiplex Oncology II panel was used to simultaneously quantify the expression levels of 92 cancer-related proteins in sera.

Results

In the discovery phase, we generated a multiprotein classifier that included CA125, HE4, ITGAV, and SEZ6L, based on an analysis of sera from 116 women with early stage ovarian cancer and 336 age-matched healthy women. CA125 alone achieved a sensitivity of 87.9% at a specificity of 95%, while the multiprotein classifier resulted

SUBMITTER: Boylan KLM 

PROVIDER: S-EPMC9264950 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature